Patient Perceptions of Antihypertensive Use as a Dementia Prevention Strategy: A Mixed-Method Analysis of a Web-Based Survey.


Journal

Journal of Alzheimer's disease : JAD
ISSN: 1875-8908
Titre abrégé: J Alzheimers Dis
Pays: Netherlands
ID NLM: 9814863

Informations de publication

Date de publication:
2019
Historique:
pubmed: 1 3 2019
medline: 15 7 2020
entrez: 1 3 2019
Statut: ppublish

Résumé

We administered a mixed-method survey to 1,661 patients in a large health system to assess preferences toward antihypertensive use for dementia prevention. If a specific antihypertensive medication was shown to prevent or delay dementia, the vast majority (>90%) of respondents currently taking an antihypertensive reported that they would be willing to take that specific antihypertensive starting as early as mid-life. Concerns reported were potential side effects, lack of evidence of effectiveness, blood pressure being normal or low, and medication cost. Analysis of free-text responses revealed themes of concerns regarding evidence of effectiveness and health priorities.

Identifiants

pubmed: 30814348
pii: JAD181080
doi: 10.3233/JAD-181080
doi:

Substances chimiques

Antihypertensive Agents 0

Types de publication

Journal Article Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

523-529

Subventions

Organisme : AHRQ HHS
ID : K12 HS022982
Pays : United States
Organisme : NIA NIH HHS
ID : K76 AG059929
Pays : United States

Auteurs

Zachary A Marcum (ZA)

University of Washington, School of Pharmacy, Seattle, WA, USA.

Sarah D Hohl (SD)

University of Washington, School of Public Health, Seattle, WA, USA.

Shelly L Gray (SL)

University of Washington, School of Pharmacy, Seattle, WA, USA.

Doug Barthold (D)

University of Washington, School of Pharmacy, Seattle, WA, USA.

Paul K Crane (PK)

University of Washington, School of Medicine, Seattle, WA, USA.

Eric B Larson (EB)

Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH